Results 21 to 30 of about 4,258 (204)

Analysis of influencing factors of perioperative myasthenic crisis in 387 myasthenia gravis patients without thymoma in a single center

Journal of Cardiothoracic Surgery, 2023
Objective To study the influencing factors of myasthenic crisis in non-thymoma myasthenia gravis (MG) patients during perioperative period. Methods We retrospectively analyzed a total of 387 non-thymoma MG patients who underwent extended thymoma ...
Peng Jiao, Fanjuan Wu, Yuxing Liu, Jiangyu Wu, Yaoguang Sun, Wenxin Tian, Hanbo Yu, Chuan Huang, Donghang Li, Qingjun Wu, Chao Ma, Hongfeng Tong   +11 more
doaj   +1 more source

Myasthenic Crisis [PDF]

The Neurohospitalist, 2011
Myasthenic crisis is a complication of myasthenia gravis characterized by worsening of muscle weakness, resulting in respiratory failure that requires intubation and mechanical ventilation. Advances in critical care have improved the mortality rate associated with myasthenic crisis.
Linda C, Wendell, Joshua M, Levine
openaire   +2 more sources

Myasthenic crisis [PDF]

QJM, 2008
Myasthenic crisis is a life-threatening medical emergency requiring early diagnosis and respiratory assistance. It can affect between one-fifth and one-third of all patients with generalized autoimmune myasthenia gravis. Myasthenic crisis is to be distinguished from other causes of acute neuromuscular paralysis which in most cases, can be achieved ...
A, Chaudhuri, P O, Behan
openaire   +2 more sources

An update on myasthenic crisis [PDF]

Current Treatment Options in Neurology, 2005
Myasthenia gravis (MG) is the most common disorder of the neuromuscular junction. Myasthenia crisis, defined as respiratory failure requiring mechanical ventilation in MG, is a common life-threatening complication that occurs in approximately 15% to 20% of patients with MG during their life time.
Shafiuddin, Ahmed, Jawad F, Kirmani, Nazli, Janjua, Ammar, Alkawi, Ismail, Khatri, Abutaher M, Yahia, Nizar, Souyah, Adnan I, Qureshi   +7 more
openaire   +2 more sources

Sweet taste loss in myasthenia gravis: more than a coincidence? [PDF]

, 2014
Sweet dysgeusia, a rare taste disorder, may be encountered in severe anti-acetylcholine receptor antibody (AChRAb)-myasthenia gravis (MG). A 42 year-old man reported progressive loss of sweet taste evolving for almost 10 weeks, revealing an AChRAb ...
Chabwine, J.N., Kuntzer, T., Landis, B.N., Tschirren, M.V., Zekeridou, A.   +4 more
core   +5 more sources

A phase 3 multicenter, prospective, open-label efficacy and safety study of immune globulin (human) 10% caprylate/chromatography purified in patients with myasthenia gravis exacerbations [PDF]

, 2019
Background: Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular transmission. Exacerbations may involve increasing bulbar weakness and/or sudden respiratory failure, both of which can be critically disabling.
Ayguasanosa, J, Balasa, R, Bril, V, Camprubi, S, Chen, J, De Bleecker, Jan, Garcia, B, Griffin, R, Heckmann, JM, Henriquez, W, Karelis, G, Lagrange, E, Mondou, E, Nicolle, M, Stuchevskaya, T, Van Damme, P, Vilciu, C, Villa, A   +17 more
core   +2 more sources

Relationship between hearing function and myasthenia gravis: a contemporary review [PDF]

, 2016
There is increasing evidence of a connection between hearing function and myasthenia gravis (MG). Studies of the pathophysiological basis of this relationship suggest that acetylcholine receptors (AChRs) on outer hair cells (OHCs) play a central role. In
ALTISSIMI, Giancarlo, CIANFRONE, Giancarlo, DI STADIO, Arianna, MAZZEI, FILIPPO, RALLI, MASSIMO, TURCHETTA, Rosaria   +5 more
core   +1 more source

Myasthenic Crisis-Induced Takotsubo Cardiomyopathy:

Translation, 2023
Please view the PDF to see the formatted meeting abstract.  
Scott Gayfield
doaj   +1 more source

Delayed Diagnosis of Atypical Presentation of Myasthenia Gravis [PDF]

, 2017
Myasthenia gravis is an autoimmune disorder affecting the neuromuscular junction, resulting in muscle fatiguability and weakness. The pathological characteristics of the disorder include ocular weakness resulting in diplopia and/or ptosis.
Ahern, Emer, Crowley, Paul, Marshal, Megan, Mustafa, Moneeb Sefeldawla   +3 more
core   +2 more sources

Myasthenia gravis [PDF]

, 2007
Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups.
Vern C Juel, Janice M Massey, A Evoli, W Hoch, J McConville, DB Sanders, F Scuderi, A Jaretzki III, LH Phillips 2nd, LH Phillips 2nd, JM Aragones, D Grob, D Grob, PI Andrews, T Santa, T Namba, LH Phillips 2nd, LY Dirr, G Moorthy, DW Mulder, NK Ragge, JF Howard, EV Stålberg, AAEM Quality Assurance Committee, American Association of Electrodiagnostic Medicine, DB Sanders, J Lindstrom, A Vincent, PI Andrews, VA Lennon, DB Sanders, FM Howard Jr, N Cikes, DB Sanders, FE Somnier, AM Yamamoto, A Mygland, Y Chagnac, N Canal, JH Frank, VC Juel, BS McEwen, RM Pascuzzi, TR Johns, C Schneider-Gold, RG Miller, ME Seybold, A Sghirlanzoni, J Palace, U Herrllinger, R Hohlfeld, JT Kissel, RS Tindall, E Ciafaloni, DB Sanders, HW Sollinger, V Chaudhry, E Ciafaloni, MN Meriggioli, D Sanders, S Vernino, MN Meriggioli, NIH Consensus Conference, AF Pinching, PC Dau, C Antozzi, P Gajdos, P Gajdos, AI Qureshi, RB Stricker, P Gajdos, C-S Huang, P Gajdos, E Tan, JB Caress, A Blalock, A Blalock, GI Wolfe, GS Gronseth, VP Perlo, M Rodriguez, DG Mulder, Y Monden, E Beghi, DJ Lanska, F Schumm, A Jaretzki III, A Jaretzki III, A Jaretzki III, GB Bulkley, HJ Oosterhuis, MS Sellman, CE Thomas, KE Osserman, JA Simpson, D Grob   +94 more
core   +3 more sources